BioSpace News Archive

Drug Development

Day One Bio Reports Mid-Stage Success in Childhood Brain Cancer

Day One Biopharmaceuticals announced positive early data assessing tovorafenib as a once-a-week treatment in people aged six months to 25 years with relapsed or progressive pediatric low-grade glioma.

June 14, 2022
·
3 min read
·
Mark Terry
Biotech Beach

BIO Returns to San Diego with Innovation and Partnering on the Menu

The annual BIO convention has returned, bringing thousands of life sciences companies worldwide to the annual networking event that could spark collaborations and deals.

June 14, 2022
·
3 min read
·
Alex Keown
Business

Pfizer-Backed Dren Nets $65M to Advance Lead Asset to Clinic

Dren Bio announced the completion a of $65M Series B financing round. New investors include Pfizer, ArrowMark Partners and Revelation Partners.

June 14, 2022
·
3 min read
·
Mark Terry
Drug Development

Leveling the Racial Playing Field for Bone Marrow Transplants

Black/African American hematological cancer patients tend to have the worst outcomes. This is partly driven by a lack of access to allogeneic hematopoietic stem cell transplant and available donors.

June 14, 2022
·
7 min read
·
Heather McKenzie
Biotech Bay

Mission Bio names Josep Carreras Leukaemia Research Institute as First Center of Excellence for Tapestri Platform in Europe

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced a new Center of Excellence, located at the Josep Carreras Leukaemia Research Institute and led by Manel Esteller, MD, PhD.

June 14, 2022
·
8 min read
Health Care Social Media Market to Register High Revenue Growth During 2021-2031

Wilmington, Delaware, United States: Social media platforms enable healthcare facilities and hospitals to connect with potential patients in order to provide valuable information to make the best health decision.

June 14, 2022
·
5 min read
Contraceptives Market to Cross the Value of US$ 2.7 Bn by 2028, Increase in Incidence of Unwanted Pregnancies to Drive Market

Wilmington, Delaware, United States: According to the report, the global contraceptives market is expected to cross US$ 2.7 Bn in 2028 and is projected to expand at a CAGR of 6.1% from 2021 to 2028.

June 14, 2022
·
5 min read
Insomnia Market Size, Shares, Trends | Global Industry Analysis Report, 2031

The global insomnia market is expected to witness a growth in the years to come on account of the increasing efficiency of drugs, brought by formulations that increase the bioavailability of a drug.

June 14, 2022
·
8 min read
Business

Scorpion Biological Services Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer (CEO)

Scorpion Biological Services, a biopharmaceutical contract development and manufacturing organization and contract research organization, announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive Officer.

June 14, 2022
·
2 min read
Pharm Country

Dr. Reddy’s Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market

Dr. Reddy’s Laboratories Ltd. announced the launch of Dr. Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar® Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration.

June 14, 2022
·
3 min read